Which broken bones lead to Life-Threatening bleeding? a new study aims to find out

NCT ID NCT07695129

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study watches 250 adults with broken leg or pelvis bones to see who develops hemorrhagic shock — a dangerous drop in blood pressure from blood loss. Researchers want to know which fractures are most likely to cause this emergency. The goal is to help doctors quickly spot and treat high-risk patients in the ER.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help emergency teams quickly identify which fracture patients are at highest risk of dangerous bleeding, potentially saving lives.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may not apply to all trauma patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients with long bone or\\and pelvic fractures presenting to the emergency department of sohag university hospital

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 18 and 65 years * Presentation with radiologically confirmed: * Long bone fractures (femur, tibia, fibula, humerus, radius, ulna) and/or * Pelvic fractures * Presentation within 24 hours of injury Exclusion Criteria: * Penetrating trauma to the abdomen and/or the chest. * Known bleeding disorders. * Patients on anticoagulants. * Major external hemorrhage requiring immediate surgical control * Isolated minor fractures (e.g., bones of hands or feet). * Dead on arrival

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhagic shock are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sohag University

    Sohag, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.